SlideShare ist ein Scribd-Unternehmen logo
1 von 15
Rajkumari Lodhi
Assistant Professor
Department of Pharmacology
Bhopal Madhya Pradesh
INTERACTIONS OF DRUGS
(COMBINED EFFECT OF DRUG)
Subject:-pharmacology-I
Semester:- 4th
Interactions of Drugs
a. Synergism
Synergism is the facilitation/potentiation of pharmacological response by concomitant use
of two drugs.
I. Potentiation
The total effect will be more than the sum of their individual effects. Examples are:
1.Acetylcholine + physostigmine. Physostigmine inhibits the action of esterase prolonging
the effect of acetylcholine.
2.Levodopa (Parkinsonism) + carbidopa/benserazide. Levo dopa is decarboxylated
peripherally, carbidopa inhibits the decarboxylase.
3.Sulfonamide (effective against some microorganisms) when combined with trimethoprim
is effective against a wider range of microorganisms.
The action is more than the normal therapeutic effect.
I. Additive Effect (Summation)
In this case the total pharmacological action of two drugs will be equal to the sum of
their individual effect on simultaneous administration. The response is not more than
their total algebraic sum.
e.g.
1.Aspirin + paracetamol as analgesic/ antipyretic
2.Ephedrine + theophylline as bronchodilator
3.Nitrous oxide + ether as general anesthetic
4.Antihypertensive drugs
5.Cardiac stimulants
b. Antagonism
When two drugs, administered simultaneously, oppose the action of each other on the
same physiological system, the phenomenon is called antagonism. It can be of following
types.
1. Chemical antagonism:
 It involves reduction of the biological activity of a drug by a chemical reaction with
another agent e.g. between acids and alkalies: BAL and arsenic.
 Antacids, used for dyspepsia involve administration of sodium bicarbonate to react with
hydrochloric acid.
 In cases of heavy metal poisoning chelating agents are used like dimerzapam.
 In iron poisoning deproxamine is given which binds sulphydral groups forming
insoluble complexes which can be easily detoxified.
2. Pharmacological antagonism
Pharmacological antagonism is of two types:
I. Competitive or reversible antagonism
In this type of antagonism the agonist and antagonist compete with each other for the
same receptors. The extent of antagonism will depend on the relative number of
receptors occupied by the two compounds. Other features are:
a. Antagonist has chemical resemblance with agonist.
b. Antagonism can be overcome by increasing the concentration of the agonist at
receptor site. It means the maximal response to agonist is not impaired.
c. Antagonist shifts the dose response curve to right
d. Emax of agonist is obtained with high concentration of agonist
e. Duration of action is short. It depends on drug clearance
II. Non competitive antagonism:
Here an antagonist inactivates the receptor in such a way so that the effective complex
with agonist cannot be formed irrespective of the concentration of the agonist. This
can happen by various ways:
1.The antagonist might combine at the same site in such a way that even higher
concentration of the agonist can not displace it.
2.The antagonist might combine at a different site of R in such a way that agonist is
unable to initiate characteristic biological response.
3.The antagonist might itself induce a certain change in R so that the reactivity of the
receptor site where agonist should interact is abolished.
II. Physiological antagonism:
In this interaction of two drugs, both are agonists, so they act at different receptor
sites. They antagonize the action of each other because they produce opposite
actions. Classical example of physiological antagonism is adrenalin and histamine.
Former causes bronchodilatation while later broncho Constriction. So adrenalin is
a life saving drug in anaphylaxis.
Clinical significance of drug antagonism
1.It helps to correct adverse effects of a drug e.g. ephedrine and phenobarbitone.
2.It is useful to treat drug poisoning e.g. morphine with naloxone
3.It guides to avoid drug combinations with reduced drug efficacy such a as
penicillin and tetracycline combination
Factors Modifying Action of Drugs
 A multitude of host & environmental factors influence drug response.
 Understanding of these factors can guide choice of appropriate drug & dose for
individual patient.
 Variation in response to the same dose of a drug between different patients and even in
the same patient on different occasions will occur.
 The range of variability may be marked or limited depending on the pharmacokinetic &
Pharmacodynamic characteristics of the drug.
 Drugs mostly disposed by metabolism are most effected (e.g. propanolol) while those
excreted by the kidneys are least effected (e.g. atenolol).
1. Physiological Factors.
2. Pathological Factors (Diseases)
3. Genetic Factors
4. Environmental Factors
5. Interaction with other drugs
There exists no specific dose.
The decision lies with the doctor.
 Giving optimum dose is mandatory for desired results.
Pharmacopoeia gives the guidelines and ranges.
All factors affecting absorption and biotransformation may
influence the outcomes of drug actions
1. Physiological Factors
a. Age
The adult dose is for people between 18 and 60 years of age. The tissues of an infant & child are highly sensitive
to large number of drugs. Children under 12 yrs require fraction of adult dose because:
1.Drug metabolizing enzyme system is inefficient in them (Glucuronidation takes 3 months to develop)
2.Their barriers are not fully developed (BBB, blood aqueous barrier), thus are more sensitive to CNS stimulants.
All parts of the body are affected by the drug.
3.Infants have an immature renal tubular transport system. Penicillin, streptomycin and amino glycosides are not
administered. After one year of age, elimination by kidneys is increased.
4.Hepatic metabolizing capacity is also under developed. Chloramphenicol may cause grey baby syndrome.
The dose for a child is calculated from the adult dose up to 8 yrs of age.
The average adult dose is for an individual of medium built. For very thin or obese individual the dose may be
modified using either the body surface area or body weight. i.e.
b. Sex
Testosterone increases the rate of biotransformation of drugs.
Decreased metabolism of some drugs in female (Diazepam) occurs. Females are more susceptible to
autonomic drugs (estrogen inhibits choline esterase). Drugs used for ulcer may cause increased
prolactin.
During menstruation, salicylates and strong purgatives should be avoided as they may increase
bleeding.
c. Pregnancy
In pregnancy following are to be considered:
1.Cardiac output
2.GFR and renal elimination of drugs.
3.Volume of distribution
4.Metabolic rate of some drugs
Lipophilic drugs cross placental barrier & are slowly excreted. During pregnancy, uterine stimulants,
strong purgatives and drugs likely to have teratogenic effects should be avoided, especially during first
trimester no drug should be given unless absolutely necessary.
During labour, morphine should be avoided as it crosses placental barrier and depresses respiration in
newborn.
. Plasma Protein Binding
Malnutrition causes decreased amino acids, decreased proteins leading to decreased
binding sites for drugs.
e. Body weight
Dose is given per kg body weight. Average muscular weight is between 50 and 100 kg,
with 70 kg being the average.
f. Lactation
During lactation, drugs may be excreted through milk and may affect the infant e.g.
some purgatives, penicillin, chloramphenicol and oral anticoagulants.
g. Food
Drugs are better absorbed in empty stomach. To prevent gastric irritation most drugs are
taken after or between foods, which affects the outcomes. Antimotion drugs are taken on
empty stomach. Helminthes (for evacuation of worms) are also taken on empty stomach.
2. Pathological Factors
Diseases cause individual variation in drug response
(A) Liver Disease
In liver diseases, prolong duration of action occurs because of increased half life. Plasma
protein binding for warfarin, tolbutamide is decreased leading to adverse effects
If hepatic blood flow is reduced, clearance of morphine- propanolol may be affected.
Impaired liver microsomal enzymes may lead to toxic levels of Diazepam, rifampicin and
theophylline
(B) Renal Disease
GFR, tabular function and plasma albumin may be affected leading to abnormal effects of
digoxin, lithium, gentamycin and penicillin
(C) Malnutrition
Plasma protein binding of drugs is reduced along with the amount of microsomal enzymes,
leading to increased portion of free, unbound drug e.g. Warfarin
3. Genetic Factors
Genetic abnormalities influence the dose of a drug and response to drugs. It affects
the drug response in individuals at 2 levels.
1.At the level of receptors
2.At the level of drugs metabolizing enzyme
Thus, interfering with the functions such as rate of plasma drug clearance.
Pharmacogenetics is the study of the relationship between genetic factors and drug
response.
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt?

Introduction to Neuropharmacology
Introduction to Neuropharmacology Introduction to Neuropharmacology
Introduction to Neuropharmacology Dr Htet
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DKameshwaran Sugavanam
 
Pharmacology of Bradykinin , pentagastrin, cholecystokinin and angiotensin
Pharmacology of Bradykinin , pentagastrin, cholecystokinin and angiotensinPharmacology of Bradykinin , pentagastrin, cholecystokinin and angiotensin
Pharmacology of Bradykinin , pentagastrin, cholecystokinin and angiotensinKoppala RVS Chaitanya
 
Neurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemNeurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemSONALPANDE5
 
Narcotics and Non-Narcotics Analgesics.pptx
Narcotics and Non-Narcotics Analgesics.pptxNarcotics and Non-Narcotics Analgesics.pptx
Narcotics and Non-Narcotics Analgesics.pptxFarazaJaved
 
Parasympathomimetics (Cholinergic drugs)
Parasympathomimetics (Cholinergic drugs)Parasympathomimetics (Cholinergic drugs)
Parasympathomimetics (Cholinergic drugs)A M O L D E O R E
 
b5. 5HT- Antagonists.pdf
b5. 5HT- Antagonists.pdfb5. 5HT- Antagonists.pdf
b5. 5HT- Antagonists.pdfVISHALJADHAV100
 
Neurohumoral Transmission in CNS
Neurohumoral Transmission in CNSNeurohumoral Transmission in CNS
Neurohumoral Transmission in CNSRaveena Chauhan
 
Cholinergic agent: Autonomic Drugs
Cholinergic agent: Autonomic DrugsCholinergic agent: Autonomic Drugs
Cholinergic agent: Autonomic DrugsRabindraAdhikary
 
Neurohumoral transission in CNS
Neurohumoral transission in CNSNeurohumoral transission in CNS
Neurohumoral transission in CNSDekollu Suku
 
(Autocoids) Histamine Pharmacology ppt
(Autocoids) Histamine Pharmacology ppt(Autocoids) Histamine Pharmacology ppt
(Autocoids) Histamine Pharmacology pptPranatiChavan
 
Sedative and hypnotics
Sedative and hypnoticsSedative and hypnotics
Sedative and hypnoticsajinkya chavan
 

Was ist angesagt? (20)

Introduction to Neuropharmacology
Introduction to Neuropharmacology Introduction to Neuropharmacology
Introduction to Neuropharmacology
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
 
Pharmacology of Bradykinin , pentagastrin, cholecystokinin and angiotensin
Pharmacology of Bradykinin , pentagastrin, cholecystokinin and angiotensinPharmacology of Bradykinin , pentagastrin, cholecystokinin and angiotensin
Pharmacology of Bradykinin , pentagastrin, cholecystokinin and angiotensin
 
2.2.1 neurohumoral transmission
2.2.1 neurohumoral transmission2.2.1 neurohumoral transmission
2.2.1 neurohumoral transmission
 
Neurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemNeurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous system
 
Sympathomimetics.pptx
Sympathomimetics.pptxSympathomimetics.pptx
Sympathomimetics.pptx
 
Narcotics and Non-Narcotics Analgesics.pptx
Narcotics and Non-Narcotics Analgesics.pptxNarcotics and Non-Narcotics Analgesics.pptx
Narcotics and Non-Narcotics Analgesics.pptx
 
Parasympathomimetics (Cholinergic drugs)
Parasympathomimetics (Cholinergic drugs)Parasympathomimetics (Cholinergic drugs)
Parasympathomimetics (Cholinergic drugs)
 
b5. 5HT- Antagonists.pdf
b5. 5HT- Antagonists.pdfb5. 5HT- Antagonists.pdf
b5. 5HT- Antagonists.pdf
 
Lect 2 Sedative-Hypnotic and Anxiolytic Drugs
Lect 2 Sedative-Hypnotic and Anxiolytic DrugsLect 2 Sedative-Hypnotic and Anxiolytic Drugs
Lect 2 Sedative-Hypnotic and Anxiolytic Drugs
 
Neurohumoral Transmission in CNS
Neurohumoral Transmission in CNSNeurohumoral Transmission in CNS
Neurohumoral Transmission in CNS
 
Parasympathomimetic drugs
Parasympathomimetic drugsParasympathomimetic drugs
Parasympathomimetic drugs
 
Cholinergic agent: Autonomic Drugs
Cholinergic agent: Autonomic DrugsCholinergic agent: Autonomic Drugs
Cholinergic agent: Autonomic Drugs
 
Autocoids
AutocoidsAutocoids
Autocoids
 
Neurohumoral transission in CNS
Neurohumoral transission in CNSNeurohumoral transission in CNS
Neurohumoral transission in CNS
 
(Autocoids) Histamine Pharmacology ppt
(Autocoids) Histamine Pharmacology ppt(Autocoids) Histamine Pharmacology ppt
(Autocoids) Histamine Pharmacology ppt
 
Dopamine gaba glutamte
Dopamine gaba glutamteDopamine gaba glutamte
Dopamine gaba glutamte
 
Hallucinogens pharmacology
Hallucinogens pharmacologyHallucinogens pharmacology
Hallucinogens pharmacology
 
Substance p
Substance pSubstance p
Substance p
 
Sedative and hypnotics
Sedative and hypnoticsSedative and hypnotics
Sedative and hypnotics
 

Ähnlich wie COMBINED EFFECT OF DRUG.pptx

Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhhPharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhhDRSURYANITHISHMANICK
 
Pharmacol lab report
Pharmacol lab reportPharmacol lab report
Pharmacol lab reportBrian Musalo
 
Factors modifying drug action
Factors modifying drug action   Factors modifying drug action
Factors modifying drug action Ansumansahoo15
 
Posology and Factors affecting to posology
Posology and Factors affecting to posologyPosology and Factors affecting to posology
Posology and Factors affecting to posologyChitralekhaTherkar
 
Factors affecting drug action in Pharmacology
Factors affecting drug action in PharmacologyFactors affecting drug action in Pharmacology
Factors affecting drug action in PharmacologyA M O L D E O R E
 
FACTORS MODIFYING DRUG ACTION
FACTORS MODIFYING DRUG ACTIONFACTORS MODIFYING DRUG ACTION
FACTORS MODIFYING DRUG ACTIONHeena Parveen
 
unit 1 Posology and dose calculation for child.pdf
unit 1 Posology and dose calculation for child.pdfunit 1 Posology and dose calculation for child.pdf
unit 1 Posology and dose calculation for child.pdfAkankshaPatel55
 
02 Drug interactions in pharmacology.ppt
02 Drug interactions in pharmacology.ppt02 Drug interactions in pharmacology.ppt
02 Drug interactions in pharmacology.pptSamiAlathwari
 

Ähnlich wie COMBINED EFFECT OF DRUG.pptx (20)

Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhhPharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
 
Pharmacol lab report
Pharmacol lab reportPharmacol lab report
Pharmacol lab report
 
Factors modifying drug action
Factors modifying drug action   Factors modifying drug action
Factors modifying drug action
 
Posology and Factors affecting to posology
Posology and Factors affecting to posologyPosology and Factors affecting to posology
Posology and Factors affecting to posology
 
Pharmacodynamics.pptx
Pharmacodynamics.pptxPharmacodynamics.pptx
Pharmacodynamics.pptx
 
posology.pptx
posology.pptxposology.pptx
posology.pptx
 
Pharmacovigila final 2
Pharmacovigila final 2Pharmacovigila final 2
Pharmacovigila final 2
 
Factors affecting drug action in Pharmacology
Factors affecting drug action in PharmacologyFactors affecting drug action in Pharmacology
Factors affecting drug action in Pharmacology
 
Posology.pptx
Posology.pptxPosology.pptx
Posology.pptx
 
FACTORS MODIFYING DRUG ACTION
FACTORS MODIFYING DRUG ACTIONFACTORS MODIFYING DRUG ACTION
FACTORS MODIFYING DRUG ACTION
 
Drug interactions
Drug interactionsDrug interactions
Drug interactions
 
2 posology
2 posology2 posology
2 posology
 
Drug distribution sjk
Drug distribution  sjkDrug distribution  sjk
Drug distribution sjk
 
unit 1 Posology and dose calculation for child.pdf
unit 1 Posology and dose calculation for child.pdfunit 1 Posology and dose calculation for child.pdf
unit 1 Posology and dose calculation for child.pdf
 
Naveen 19
Naveen 19Naveen 19
Naveen 19
 
posology ppt.pptx
posology ppt.pptxposology ppt.pptx
posology ppt.pptx
 
02 Drug interactions in pharmacology.ppt
02 Drug interactions in pharmacology.ppt02 Drug interactions in pharmacology.ppt
02 Drug interactions in pharmacology.ppt
 
posology.pptx
posology.pptxposology.pptx
posology.pptx
 
Drug interaction
Drug interactionDrug interaction
Drug interaction
 

Mehr von rajkumarilodhi

Exploring-the-Fascinating-World-of-Virus-Replication-Cycle (1).pptx
Exploring-the-Fascinating-World-of-Virus-Replication-Cycle (1).pptxExploring-the-Fascinating-World-of-Virus-Replication-Cycle (1).pptx
Exploring-the-Fascinating-World-of-Virus-Replication-Cycle (1).pptxrajkumarilodhi
 
History and scope of microbiology.pptx
History and scope of microbiology.pptxHistory and scope of microbiology.pptx
History and scope of microbiology.pptxrajkumarilodhi
 
cellbiology patho.pptx
cellbiology patho.pptxcellbiology patho.pptx
cellbiology patho.pptxrajkumarilodhi
 
cellcycleanditsregulation11.pptx
cellcycleanditsregulation11.pptxcellcycleanditsregulation11.pptx
cellcycleanditsregulation11.pptxrajkumarilodhi
 
Hypertension, Diabetes, Cancer, Drug addiction and drug abuse.pptx
Hypertension, Diabetes, Cancer, Drug addiction and drug abuse.pptxHypertension, Diabetes, Cancer, Drug addiction and drug abuse.pptx
Hypertension, Diabetes, Cancer, Drug addiction and drug abuse.pptxrajkumarilodhi
 
ANTOPSYCHOTICS ANTIDEPRESENT DRUGD ANTIANXIETY DRUGS HALLUCINATION.pptx
ANTOPSYCHOTICS ANTIDEPRESENT DRUGD ANTIANXIETY DRUGS HALLUCINATION.pptxANTOPSYCHOTICS ANTIDEPRESENT DRUGD ANTIANXIETY DRUGS HALLUCINATION.pptx
ANTOPSYCHOTICS ANTIDEPRESENT DRUGD ANTIANXIETY DRUGS HALLUCINATION.pptxrajkumarilodhi
 
AVERSE DRUG REACTION3.pptx
AVERSE DRUG REACTION3.pptxAVERSE DRUG REACTION3.pptx
AVERSE DRUG REACTION3.pptxrajkumarilodhi
 
MENZYME INDUCTION 3.pptx
MENZYME INDUCTION 3.pptxMENZYME INDUCTION 3.pptx
MENZYME INDUCTION 3.pptxrajkumarilodhi
 
3Health and desease(8th).pptx
3Health and desease(8th).pptx3Health and desease(8th).pptx
3Health and desease(8th).pptxrajkumarilodhi
 

Mehr von rajkumarilodhi (12)

Exploring-the-Fascinating-World-of-Virus-Replication-Cycle (1).pptx
Exploring-the-Fascinating-World-of-Virus-Replication-Cycle (1).pptxExploring-the-Fascinating-World-of-Virus-Replication-Cycle (1).pptx
Exploring-the-Fascinating-World-of-Virus-Replication-Cycle (1).pptx
 
History and scope of microbiology.pptx
History and scope of microbiology.pptxHistory and scope of microbiology.pptx
History and scope of microbiology.pptx
 
cellbiology patho.pptx
cellbiology patho.pptxcellbiology patho.pptx
cellbiology patho.pptx
 
cellcycleanditsregulation11.pptx
cellcycleanditsregulation11.pptxcellcycleanditsregulation11.pptx
cellcycleanditsregulation11.pptx
 
Hypertension, Diabetes, Cancer, Drug addiction and drug abuse.pptx
Hypertension, Diabetes, Cancer, Drug addiction and drug abuse.pptxHypertension, Diabetes, Cancer, Drug addiction and drug abuse.pptx
Hypertension, Diabetes, Cancer, Drug addiction and drug abuse.pptx
 
BALANCED DIET
BALANCED DIET BALANCED DIET
BALANCED DIET
 
ANTOPSYCHOTICS ANTIDEPRESENT DRUGD ANTIANXIETY DRUGS HALLUCINATION.pptx
ANTOPSYCHOTICS ANTIDEPRESENT DRUGD ANTIANXIETY DRUGS HALLUCINATION.pptxANTOPSYCHOTICS ANTIDEPRESENT DRUGD ANTIANXIETY DRUGS HALLUCINATION.pptx
ANTOPSYCHOTICS ANTIDEPRESENT DRUGD ANTIANXIETY DRUGS HALLUCINATION.pptx
 
AVERSE DRUG REACTION3.pptx
AVERSE DRUG REACTION3.pptxAVERSE DRUG REACTION3.pptx
AVERSE DRUG REACTION3.pptx
 
MENZYME INDUCTION 3.pptx
MENZYME INDUCTION 3.pptxMENZYME INDUCTION 3.pptx
MENZYME INDUCTION 3.pptx
 
4th sem 3.pptx
4th sem 3.pptx4th sem 3.pptx
4th sem 3.pptx
 
3public health.pptx
3public health.pptx3public health.pptx
3public health.pptx
 
3Health and desease(8th).pptx
3Health and desease(8th).pptx3Health and desease(8th).pptx
3Health and desease(8th).pptx
 

Kürzlich hochgeladen

Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 

Kürzlich hochgeladen (20)

INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 

COMBINED EFFECT OF DRUG.pptx

  • 1. Rajkumari Lodhi Assistant Professor Department of Pharmacology Bhopal Madhya Pradesh INTERACTIONS OF DRUGS (COMBINED EFFECT OF DRUG) Subject:-pharmacology-I Semester:- 4th
  • 2. Interactions of Drugs a. Synergism Synergism is the facilitation/potentiation of pharmacological response by concomitant use of two drugs. I. Potentiation The total effect will be more than the sum of their individual effects. Examples are: 1.Acetylcholine + physostigmine. Physostigmine inhibits the action of esterase prolonging the effect of acetylcholine. 2.Levodopa (Parkinsonism) + carbidopa/benserazide. Levo dopa is decarboxylated peripherally, carbidopa inhibits the decarboxylase. 3.Sulfonamide (effective against some microorganisms) when combined with trimethoprim is effective against a wider range of microorganisms. The action is more than the normal therapeutic effect.
  • 3. I. Additive Effect (Summation) In this case the total pharmacological action of two drugs will be equal to the sum of their individual effect on simultaneous administration. The response is not more than their total algebraic sum. e.g. 1.Aspirin + paracetamol as analgesic/ antipyretic 2.Ephedrine + theophylline as bronchodilator 3.Nitrous oxide + ether as general anesthetic 4.Antihypertensive drugs 5.Cardiac stimulants b. Antagonism When two drugs, administered simultaneously, oppose the action of each other on the same physiological system, the phenomenon is called antagonism. It can be of following types.
  • 4. 1. Chemical antagonism:  It involves reduction of the biological activity of a drug by a chemical reaction with another agent e.g. between acids and alkalies: BAL and arsenic.  Antacids, used for dyspepsia involve administration of sodium bicarbonate to react with hydrochloric acid.  In cases of heavy metal poisoning chelating agents are used like dimerzapam.  In iron poisoning deproxamine is given which binds sulphydral groups forming insoluble complexes which can be easily detoxified.
  • 5. 2. Pharmacological antagonism Pharmacological antagonism is of two types: I. Competitive or reversible antagonism In this type of antagonism the agonist and antagonist compete with each other for the same receptors. The extent of antagonism will depend on the relative number of receptors occupied by the two compounds. Other features are: a. Antagonist has chemical resemblance with agonist. b. Antagonism can be overcome by increasing the concentration of the agonist at receptor site. It means the maximal response to agonist is not impaired. c. Antagonist shifts the dose response curve to right d. Emax of agonist is obtained with high concentration of agonist e. Duration of action is short. It depends on drug clearance
  • 6. II. Non competitive antagonism: Here an antagonist inactivates the receptor in such a way so that the effective complex with agonist cannot be formed irrespective of the concentration of the agonist. This can happen by various ways: 1.The antagonist might combine at the same site in such a way that even higher concentration of the agonist can not displace it. 2.The antagonist might combine at a different site of R in such a way that agonist is unable to initiate characteristic biological response. 3.The antagonist might itself induce a certain change in R so that the reactivity of the receptor site where agonist should interact is abolished.
  • 7. II. Physiological antagonism: In this interaction of two drugs, both are agonists, so they act at different receptor sites. They antagonize the action of each other because they produce opposite actions. Classical example of physiological antagonism is adrenalin and histamine. Former causes bronchodilatation while later broncho Constriction. So adrenalin is a life saving drug in anaphylaxis. Clinical significance of drug antagonism 1.It helps to correct adverse effects of a drug e.g. ephedrine and phenobarbitone. 2.It is useful to treat drug poisoning e.g. morphine with naloxone 3.It guides to avoid drug combinations with reduced drug efficacy such a as penicillin and tetracycline combination
  • 8. Factors Modifying Action of Drugs  A multitude of host & environmental factors influence drug response.  Understanding of these factors can guide choice of appropriate drug & dose for individual patient.  Variation in response to the same dose of a drug between different patients and even in the same patient on different occasions will occur.  The range of variability may be marked or limited depending on the pharmacokinetic & Pharmacodynamic characteristics of the drug.  Drugs mostly disposed by metabolism are most effected (e.g. propanolol) while those excreted by the kidneys are least effected (e.g. atenolol).
  • 9. 1. Physiological Factors. 2. Pathological Factors (Diseases) 3. Genetic Factors 4. Environmental Factors 5. Interaction with other drugs There exists no specific dose. The decision lies with the doctor.  Giving optimum dose is mandatory for desired results. Pharmacopoeia gives the guidelines and ranges. All factors affecting absorption and biotransformation may influence the outcomes of drug actions
  • 10. 1. Physiological Factors a. Age The adult dose is for people between 18 and 60 years of age. The tissues of an infant & child are highly sensitive to large number of drugs. Children under 12 yrs require fraction of adult dose because: 1.Drug metabolizing enzyme system is inefficient in them (Glucuronidation takes 3 months to develop) 2.Their barriers are not fully developed (BBB, blood aqueous barrier), thus are more sensitive to CNS stimulants. All parts of the body are affected by the drug. 3.Infants have an immature renal tubular transport system. Penicillin, streptomycin and amino glycosides are not administered. After one year of age, elimination by kidneys is increased. 4.Hepatic metabolizing capacity is also under developed. Chloramphenicol may cause grey baby syndrome. The dose for a child is calculated from the adult dose up to 8 yrs of age. The average adult dose is for an individual of medium built. For very thin or obese individual the dose may be modified using either the body surface area or body weight. i.e.
  • 11. b. Sex Testosterone increases the rate of biotransformation of drugs. Decreased metabolism of some drugs in female (Diazepam) occurs. Females are more susceptible to autonomic drugs (estrogen inhibits choline esterase). Drugs used for ulcer may cause increased prolactin. During menstruation, salicylates and strong purgatives should be avoided as they may increase bleeding. c. Pregnancy In pregnancy following are to be considered: 1.Cardiac output 2.GFR and renal elimination of drugs. 3.Volume of distribution 4.Metabolic rate of some drugs Lipophilic drugs cross placental barrier & are slowly excreted. During pregnancy, uterine stimulants, strong purgatives and drugs likely to have teratogenic effects should be avoided, especially during first trimester no drug should be given unless absolutely necessary. During labour, morphine should be avoided as it crosses placental barrier and depresses respiration in newborn.
  • 12. . Plasma Protein Binding Malnutrition causes decreased amino acids, decreased proteins leading to decreased binding sites for drugs. e. Body weight Dose is given per kg body weight. Average muscular weight is between 50 and 100 kg, with 70 kg being the average. f. Lactation During lactation, drugs may be excreted through milk and may affect the infant e.g. some purgatives, penicillin, chloramphenicol and oral anticoagulants. g. Food Drugs are better absorbed in empty stomach. To prevent gastric irritation most drugs are taken after or between foods, which affects the outcomes. Antimotion drugs are taken on empty stomach. Helminthes (for evacuation of worms) are also taken on empty stomach.
  • 13. 2. Pathological Factors Diseases cause individual variation in drug response (A) Liver Disease In liver diseases, prolong duration of action occurs because of increased half life. Plasma protein binding for warfarin, tolbutamide is decreased leading to adverse effects If hepatic blood flow is reduced, clearance of morphine- propanolol may be affected. Impaired liver microsomal enzymes may lead to toxic levels of Diazepam, rifampicin and theophylline (B) Renal Disease GFR, tabular function and plasma albumin may be affected leading to abnormal effects of digoxin, lithium, gentamycin and penicillin (C) Malnutrition Plasma protein binding of drugs is reduced along with the amount of microsomal enzymes, leading to increased portion of free, unbound drug e.g. Warfarin
  • 14. 3. Genetic Factors Genetic abnormalities influence the dose of a drug and response to drugs. It affects the drug response in individuals at 2 levels. 1.At the level of receptors 2.At the level of drugs metabolizing enzyme Thus, interfering with the functions such as rate of plasma drug clearance. Pharmacogenetics is the study of the relationship between genetic factors and drug response.